Showing results (1501-1510 of 1,592) with videos related to
Sort By:
Pageof 160
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditionsClaus V Hallwirth, Gagan Garg, Timothy J Peters, et al.Journal of Child and Adolescent Psychopharmacology|March 24, 2016
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating ScaleHanna Kovshoff, Tobias Banaschewski, Jan K Buitelaar, et al.Bioorganic & Medicinal Chemistry Letters|April 8, 2009
4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitorsJohn Liddle, Paul Bamborough, Michael D Barker, et al.Journal of Medicinal Chemistry|January 14, 2012
Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potencyAlan D Borthwick, John Liddle, Dave E Davies, et al.Cell Reports|June 30, 2021
FGF21 promotes thermogenic gene expression as an autocrine factor in adipocytesMohammad Abu-Odeh, Yuan Zhang, Shannon M Reilly, et al.Nephrology (Carlton, Vic.)|August 9, 2025
Patient Needs and Priorities for a Goal-Setting Intervention in Kidney Transplant Recipients: A Workshop ReportColm O'Reilly, Dale Coghlan, Anastasia Hughes, et al.Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2016
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitorsNeil S Garton, Michael D Barker, Rob P Davis, et al.Nature Medicine|February 12, 2013
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceShannon M Reilly, Shian-Huey Chiang, Stuart J Decker, et al.Age and Ageing|March 23, 2026
Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson's diseaseDana Pourzinal, Deborah Brooks, Deepa Sriram, et al.Pageof 160